Cargando…
Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia
Autores principales: | Lai, Xiaofei, Wang, Jing, Duan, Jun, Gong, Yi, Cao, Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701768/ https://www.ncbi.nlm.nih.gov/pubmed/34954255 http://dx.doi.org/10.1016/j.jinf.2021.12.027 |
Ejemplares similares
-
Clinicomicrobiological study of community-acquired pneumonia
por: Prasad, Prashasti, et al.
Publicado: (2017) -
Interleukin-34: an important modifier in the pathogenesis of influenza pneumonia
por: Xu, Banglao, et al.
Publicado: (2021) -
Significance of Anaerobes and Oral Bacteria in Community-Acquired Pneumonia
por: Yamasaki, Kei, et al.
Publicado: (2013) -
The clinical efficacy of lefamulin in the treatment of elderly patients with community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020) -
Resistance of gram negative bacteria in hospital acquired pneumonia: a prospective study
por: Dehghan, Farzaneh, et al.
Publicado: (2015)